Literature DB >> 33973496

Knockdown of CENPW Inhibits Hepatocellular Carcinoma Progression by Inactivating E2F Signaling.

Yajing Zhou1, Hua Chai2, Lei Guo3, Zhongqiu Dai3, Jianming Lai4, Jianping Duan3, Yanting Liu5, Qian Ding3.   

Abstract

AIM: This study aimed to evaluate the effects of centromere protein W (CENPW, also known as CUG2) in hepatocellular carcinoma (HCC).
METHODS: CENPW expression in HCC tissues and cells was detected by RT-qPCR assay. CCK-8 and colony formation assay were used to assess cell proliferation. Wound healing and Transwell assay was used to detect cell migration and invasion, respectively. The flow cytometry was used to analyze the cell cycle distribution and apoptosis.
RESULTS: CENPW expression was upregulated in HCC tissues and cells. Knockdown of CENPW inhibited cell proliferation, migration, and invasion and induced the G0/G1 phase arrest and cell apoptosis in HCC cells, which might involve the E2F signaling regulation.
CONCLUSION: CENPW acted as an oncogenic role in HCC progression via activation E2F signaling. Our findings may provide new insights into the studying mechanisms of HCC.

Entities:  

Keywords:  CENPW (also known as CUG2); E2F signaling; cell cycle; cell proliferation; hepatocellular carcinoma

Year:  2021        PMID: 33973496     DOI: 10.1177/15330338211007253

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  2 in total

1.  Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.

Authors:  Jiaqi Zhu; Jinjie Wang; Tianyi Wang; Hao Zhou; Mingming Xu; Jiliang Zha; Chen Feng; Zihao Shen; Yun Jiang; Jianle Chen
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

2.  Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma.

Authors:  Luyang Wang; Hairui Wang; Chen Yang; Yunyi Wu; Guojie Lei; Yanhua Yu; Yan Gao; Jing Du; Xiangmin Tong; Feifei Zhou; Yanchun Li; Ying Wang
Journal:  Front Genet       Date:  2022-06-17       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.